Search Results - Patrick J. Roberts

  • Showing 1 - 18 results of 18
Refine Results
  1. 1
    PRESYNAPTIC γ‐AMINOBUTYRIC ACID RECEPTORS IN THE RAT ANOCOCCYGEUS MUSCLE AND THEIR ANTAGONISM BY 5‐AMINOVALERIC ACID

    PRESYNAPTIC γ‐AMINOBUTYRIC ACID RECEPTORS IN THE RAT ANOCOCCYGEUS MUSCLE AND THEIR ANTAGONISM BY 5‐AMINOVALERIC ACID by M.Sherwan Muhyaddin, Patrick J. Roberts, G.N. Woodruff

    Published 1982
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Chemotherapy and CDK4/6 Inhibitors: Unexpected Bedfellows

    Chemotherapy and CDK4/6 Inhibitors: Unexpected Bedfellows by Patrick J. Roberts, Vishnu Kumarasamy, Agnieszka K. Witkiewicz, Erik S. Knudsen

    Published 2020
    Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Preclinical Characterization of G1T28: A Novel CDK4/6 Inhibitor for Reduction of Chemotherapy-Induced Myelosuppression

    Preclinical Characterization of G1T28: A Novel CDK4/6 Inhibitor for Reduction of Chemotherapy-Induced Myelosuppression by John E. Bisi, Jessica A. Sorrentino, Patrick J. Roberts, Francis X. Tavares, Jay C. Strum

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Preclinical development of G1T38: A novel, potent and selective inhibitor of cyclin dependent kinases 4/6 for use as an oral antineoplastic in patients with CDK4/6 sensitive tumors

    Preclinical development of G1T38: A novel, potent and selective inhibitor of cyclin dependent kinases 4/6 for use as an oral antineoplastic in patients with CDK4/6 sensitive tumors by John E. Bisi, Jessica A. Sorrentino, Jamie L. Jordan, David D. Darr, Patrick J. Roberts, Francis X. Tavares, Jay C. Strum

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    CDK4/6 inhibition induces epithelial cell cycle arrest and ameliorates acute kidney injury

    CDK4/6 inhibition induces epithelial cell cycle arrest and ameliorates acute kidney injury by Derek P. DiRocco, John E. Bisi, Patrick J. Roberts, Jay C. Strum, Kwok‐Kin Wong, Norman E. Sharpless, Benjamin D. Humphreys

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Rho Family GTPase Modification and Dependence on CAAX Motif-signaled Posttranslational Modification

    Rho Family GTPase Modification and Dependence on CAAX Motif-signaled Posttranslational Modification by Patrick J. Roberts, Natalia Mitin, Patricia J. Keller, Emily J. Chenette, James P. Madigan, Rachel O. Currin, Adrienne D. Cox, Oswald Wilson, Paul T. Kirschmeier, Channing J. Der

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    CDK4/6 inhibition enhances antitumor efficacy of chemotherapy and immune checkpoint inhibitor combinations in preclinical models and enhances T-cell activation in patients with SCLC receiving chemotherapy

    CDK4/6 inhibition enhances antitumor efficacy of chemotherapy and immune checkpoint inhibitor combinations in preclinical models and enhances T-cell activation in patients with SCL... by Anne Y. Lai, Jessica A. Sorrentino, Konstantin H. Dragnev, Jared Weiss, Taofeek K. Owonikoko, Julie Rytlewski, Jill Hood, Yang Zhao, Rajesh Malik, Jay C. Strum, Patrick J. Roberts

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Multiple Roles of Cyclin-Dependent Kinase 4/6 Inhibitors in Cancer Therapy

    Multiple Roles of Cyclin-Dependent Kinase 4/6 Inhibitors in Cancer Therapy by Patrick J. Roberts, John E. Bisi, Jay C. Strum, Austin J. Combest, David B. Darr, Jerry Usary, William C. Zamboni, Kwok‐Kin Wong, Charles M. Perou, Norman E. Sharpless

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Transient CDK4/6 inhibition protects hematopoietic stem cells from chemotherapy-induced exhaustion

    Transient CDK4/6 inhibition protects hematopoietic stem cells from chemotherapy-induced exhaustion by Shenghui He, Patrick J. Roberts, Jessica A. Sorrentino, John E. Bisi, Hannah Storrie-White, Renger G. Tiessen, Karenann M. Makhuli, William A. Wargin, Henko Tadema, Ewoud-Jan van Hoogdalem, Jay C. Strum, Rajesh Malik, Norman E. Sharpless

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Combined PI3K/mTOR and MEK Inhibition Provides Broad Antitumor Activity in Faithful Murine Cancer Models

    Combined PI3K/mTOR and MEK Inhibition Provides Broad Antitumor Activity in Faithful Murine Cancer Models by Patrick J. Roberts, Jerry Usary, David B. Darr, Patrick M. Dillon, Adam D. Pfefferle, Martin C. Whittle, James S. Duncan, Søren M. Johnson, Austin J. Combest, Jian Jin, William C. Zamboni, Gary L. Johnson, Charles M. Perou, Norman E. Sharpless

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid Tumors

    INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid Tumors by Catherine Dietrich, Alec Trub, Antonio Ahn, Michael Taylor, Krutika Ambani, Keefe T. Chan, Kun‐Hui Lu, Christabella A. Mahendra, Catherine Blyth, Rhiannon Coulson, Susanne Ramm, April C. Watt, Sunil Kumar Matsa, John E. Bisi, Jay C. Strum, Patrick J. Roberts, Shom Goel

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Discrete vulnerability to pharmacological CDK2 inhibition is governed by heterogeneity of the cancer cell cycle

    Discrete vulnerability to pharmacological CDK2 inhibition is governed by heterogeneity of the cancer cell cycle by Vishnu Kumarasamy, Jianxin Wang, Michelle Roti, Yin Wan, Adam P. Dommer, Hanna R. Rosenheck, Sivasankar Putta, Alec Trub, John E. Bisi, Jay C. Strum, Patrick J. Roberts, Seth M. Rubin, Costakis Frangou, Karen McLean, Agnieszka K. Witkiewicz, Erik S. Knudsen

    Published 2025
    Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Predicting Drug Responsiveness in Human Cancers Using Genetically Engineered Mice

    Predicting Drug Responsiveness in Human Cancers Using Genetically Engineered Mice by Jerry Usary, Wei Zhao, David B. Darr, Patrick J. Roberts, Mei Liu, Lorraine Balletta, Olga Karginova, Jamie Jordan, Austin J. Combest, Arlene S. Bridges, Aleix Prat, Maggie C.U. Cheang, Jason I. Herschkowitz, Jeffrey M. Rosen, William C. Zamboni, Norman E. Sharpless, Charles M. Perou

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Alterations of LKB1 and KRAS and risk of brain metastasis: Comprehensive characterization by mutation analysis, copy number, and gene expression in non-small-cell lung carcinoma

    Alterations of LKB1 and KRAS and risk of brain metastasis: Comprehensive characterization by mutation analysis, copy number, and gene expression in non-small-cell lung carcinoma by Ni Zhao, Matthew D. Wilkerson, Usman Shah, Xiaoying Yin, Anyou Wang, Michele C. Hayward, Patrick J. Roberts, Carrie B. Lee, Alden M. Parsons, Leigh B. Thorne, Benjamin E. Haithcock, Juneko E. Grilley‐Olson, Thomas E. Stinchcombe, William K. Funkhouser, Kwok‐Kin Wong, Norman E. Sharpless, D. Neil Hayes

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Lung Squamous Cell Carcinoma mRNA Expression Subtypes Are Reproducible, Clinically Important, and Correspond to Normal Cell Types

    Lung Squamous Cell Carcinoma mRNA Expression Subtypes Are Reproducible, Clinically Important, and Correspond to Normal Cell Types by Matthew D. Wilkerson, Xiaoying Yin, Katherine A. Hoadley, Yufeng Liu, Michele C. Hayward, Christopher R. Cabanski, Kenneth L. Muldrew, C. Ryan Miller, Scott H. Randell, Mark A. Socinski, Alden M. Parsons, William K. Funkhouser, Carrie B. Lee, Patrick J. Roberts, Leigh B. Thorne, Philip S. Bernard, Charles M. Perou, D. Neil Hayes

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Myelopreservation with the CDK4/6 inhibitor trilaciclib in patients with small-cell lung cancer receiving first-line chemotherapy: a phase Ib/randomized phase II trial

    Myelopreservation with the CDK4/6 inhibitor trilaciclib in patients with small-cell lung cancer receiving first-line chemotherapy: a phase Ib/randomized phase II trial by J. Weiß, Tibor Csőszi, Marina Maglakelidze, Robert J. Hoyer, J.T. Beck, M. Dómine Gómez, Anna Łowczak, Raid Aljumaily, Caio M. Rocha Lima, Ralph V. Boccia, Wahid T. Hanna, Petros Nikolinakos, V.K. Chiu, Taofeek K. Owonikoko, Steven R. Schuster, Maen Hussein, Donald Richards, Piotr Sawrycki, Iurie Bulat, John Hamm, Lowell L. Hart, S. Adler, Joyce Antal, Anne Y. Lai, Jessica A. Sorrentino, Yang Zhao, Rajesh Malik, Shannon R. Morris, Patrick J. Roberts, K. Dragnev

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response

    A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response by Chen Zhao, Katherine A. Cheng, Zandra E. Walton, Yuchuan Wang, Hiromichi Ebi, Takeshi Shimamura, Yan Liu, Tanya Tupper, Jing Ouyang, Jie Li, Peng Gao, Michele Sue‐Ann Woo, Chunxiao Xu, Masahiko Yanagita, Abigail Altabef, Shumei Wang, Charles Lee, Yuji Nakada, Christopher G. Peña, Yanping Sun, Yoko Franchetti, Catherine Yao, Amy Saur, Michael D. Cameron, Mizuki Nishino, D. Neil Hayes, Matthew D. Wilkerson, Patrick J. Roberts, Carrie B. Lee, Nabeel Bardeesy, Mohit Butaney, Lucian R. Chirieac, Daniel B. Costa, David M. Jackman, Norman E. Sharpless, Diego H. Castrillón, George D. Demetri, Pasi A. Jänne, Pier Paolo Pandolfi, Lewis C. Cantley, Andrew L. Kung, Jeffrey A. Engelman, Kwok‐Kin Wong

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation

    CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation by Jiehui Deng, Eric S. Wang, Russell W. Jenkins, Shuai Li, Ruben Dries, Karen E. Yates, Sandeep Chhabra, Wei Huang, Hongye Liu, Amir Reza Aref, Elena Ivanova, Cloud P. Paweletz, Michaela Bowden, Chensheng W. Zhou, Grit S. Herter-Sprie, Jessica A. Sorrentino, John E. Bisi, Patrick H. Lizotte, Ashley A. Merlino, Max M. Quinn, Lauren E. Bufe, Annan Yang, Y. Zhang, Hua Zhang, Peng Gao, Ting Chen, Megan E. Cavanaugh, Amanda J. Rode, Eric Haines, Patrick J. Roberts, Jay C. Strum, William G. Richards, Jochen H. Lorch, Sareh Parangi, Viswanath Gunda, Genevieve M. Boland, Raphael Bueno, Sangeetha Palakurthi, Gordon J. Freeman, Jerome Ritz, W. Nicholas Haining, Norman E. Sharpless, Haribabu Arthanari, Geoffrey I. Shapiro, David A. Barbie, Nathanael S. Gray, Kwok‐Kin Wong

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: